Player FM - Internet Radio Done Right
133 subscribers
Checked 12d ago
Toegevoegd zeven jaar geleden
Inhoud geleverd door The Long Run with Luke Timmerman and Timmerman Report. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door The Long Run with Luke Timmerman and Timmerman Report of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !
Ga offline met de app Player FM !
Podcasts die het beluisteren waard zijn
GESPONSORDE
<
<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/action-academy-replace-the-job-you-hate-with-a-life-you-love">Action Academy | Replace The Job You Hate With A Life You Love</a></span>


Ready to replace your 6-figure salary with real freedom? This is the podcast for high earners who feel stuck in jobs they’ve outgrown. If you’re asking, “How do I actually replace $10K–$20K/month so I can quit and never look back?” — welcome home. At Action Academy, we teach you how to buy small businesses and commercial real estate to create cash flow that actually replaces your job. Monday through Friday, you’ll learn from 7–9 figure entrepreneurs, real estate moguls, and acquisition pros who’ve done it — and show you how to do it too. Hosted by Brian Luebben (@brianluebben), who quit his 6-figure sales role in 2022 to build a global business while traveling the world. If you're a high-income earner ready to become a high-impact entrepreneur, this show is your playbook. Subscribe now and start your path to freedom — or keep pretending your job will get better someday....
Ep162: Sean McClain on AI for Biologic Drug Discovery
Manage episode 429189565 series 2396963
Inhoud geleverd door The Long Run with Luke Timmerman and Timmerman Report. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door The Long Run with Luke Timmerman and Timmerman Report of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.
…
continue reading
175 afleveringen
Manage episode 429189565 series 2396963
Inhoud geleverd door The Long Run with Luke Timmerman and Timmerman Report. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door The Long Run with Luke Timmerman and Timmerman Report of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.
…
continue reading
175 afleveringen
Alle afleveringen
×Kevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.
T
The Long Run with Luke Timmerman


1 Ep176: David Roblin on Building a TechBio Company 1:19:28
1:19:28
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:19:28
David Roblin, CEO of London-based Relation Therapeutics, on building a techbio discovery company.
T
The Long Run with Luke Timmerman


1 Ep175: Andy Scharenberg on in vivo CAR-T cell therapies 1:10:46
1:10:46
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:10:46
Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
T
The Long Run with Luke Timmerman


1 Ep174: Najat Khan on the TechBio Movement 1:07:16
1:07:16
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:07:16
Najat Khan, chief R&D and chief commercial officer of Recursion, on using technology to improve drug discovery.
T
The Long Run with Luke Timmerman


Robert Blum, CEO of South San Francisco-based Cytokinetics, on building a fully integrated biopharma to treat muscle disorders.
T
The Long Run with Luke Timmerman


1 Ep172: Mostafa Ronaghi on Studying Live Cells at Scale 1:20:53
1:20:53
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:20:53
Mostafa Ronaghi, co-founder and executive board member of Cellanome, on developing technology to look at live cells and cellular interactions at scale.
T
The Long Run with Luke Timmerman


1 Ep171: Ram Aiyar on RNA Editing Medicines 1:01:48
1:01:48
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:01:48
Ram Aiyar, CEO of Cambridge, Mass.-based Korro Bio, on RNA editing medicines.
T
The Long Run with Luke Timmerman


David Schenkein, general partner at GV, on investing in the future of biotech.
T
The Long Run with Luke Timmerman


1 Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines 1:02:28
1:02:28
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:02:28
Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.
T
The Long Run with Luke Timmerman


1 Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer 1:00:23
1:00:23
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:00:23
Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools.
T
The Long Run with Luke Timmerman


1 Ep167: Leslie Williams on transfer RNA therapies 1:11:28
1:11:28
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:11:28
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.
T
The Long Run with Luke Timmerman


1 Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity 1:03:35
1:03:35
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:03:35
Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases.
T
The Long Run with Luke Timmerman


1 Ep165: Zach Hornby on Tackling Cancer Drug Resistance 1:02:45
1:02:45
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:02:45
Zach Hornby, CEO of San Diego-based Boundless Bio, on tackling cancer drug resistance.
T
The Long Run with Luke Timmerman


Ted Love, chairman of BIO, and Dr. Alan Anderson, executive director of Sickle Forward, on how to improve quality of life for sickle cell disease patients around the world.
T
The Long Run with Luke Timmerman


1 Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases 1:08:19
1:08:19
Later Afspelen
Later Afspelen
Lijsten
Vind ik leuk
Leuk1:08:19
Sarah Boyce, CEO of San Diego-based Avidity Biosciences, on RNA medicines for rare muscle diseases.
Welkom op Player FM!
Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.